Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] NLMUID: 8707234"" wg kryterium: JN


Tytuł :
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
Autorzy :
Luber RP; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
O'Neill R; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Singh S; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sharma E; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Cunningham G; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Honap S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Meade S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Ray S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Anderson SH; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Mawdsley J; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sanderson JD; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Samaan MA; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Arkir Z; Viapath Analytics, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Irving PM; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College London, London, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 05. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Review article: time to revisit Child-Pugh score as the basis for predicting drug clearance in hepatic impairment.
Autorzy :
El-Khateeb E; Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Darwich AS; Logistics and Informatics in Health Care, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, Stockholm, Sweden.
Achour B; Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.
Athwal V; Wellcome Centre for Cell-Matrix Research, Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.; Research and Innovation Division, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.; Certara UK Ltd. (Simcyp Division), Sheffield, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 04. Date of Electronic Publication: 2021 Jul 04.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection.
Autorzy :
Rotondo-Trivette S; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Wang B; Quantitative and Computational Biology Program, Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.; School of Mathematics, Shandong University, Jinan, China.
Gayer C; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Parsana R; Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Luan Y; School of Mathematics, Shandong University, Jinan, China.
Sun F; Quantitative and Computational Biology Program, Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.
Michail S; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 04. Date of Electronic Publication: 2021 Jul 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial: is there a 'precursor' HCC lesion and can it be detected by hepatobiliary contrast-enhanced magnetic resonance imaging? Authors' reply.
Autorzy :
Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Yasuda S; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Shiota S; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 204-205.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: on the road towards treatment of gastroparesis-accelerating but do we get closer?
Autorzy :
Wuestenberghs F; Physiology Department, INSERM 1073-CIC/CRB 1404, CHU de Rouen, Normandy University, Rouen, France.; CHU UCL Namur, Department of Gastroenterology and Hepatology, Université catholique de Louvain, Yvoir, Belgium.
Gourcerol G; Physiology Department, INSERM 1073-CIC/CRB 1404, CHU de Rouen, Normandy University, Rouen, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 183-184.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: tissue findings fail to predict disease activity or prognosis in microscopic colitis-an opportunity to look at the molecular level-authors' reply.
Autorzy :
Olsen LM; Roskilde, Denmark.
Engel PJH; Roskilde, Denmark.
Goudkade D; Geleen, The Netherlands.
Villanacci V; Brescia, Italy.
Thagaard J; Hoersholm, Denmark.; Lyngby, Denmark.
Walbech JS; Køge, Denmark.
Bohr J; Örebro, Sweden.
Kupcinskas J; Kaunas, Lithuania.
Verhaegh B; Maastricht, The Netherlands.
Münch A; Linköping, Sweden.
Guagnozzi D; Barcelona, Spain.
Fernández-Bañares F; Barcelona, Spain.
Munck LK; Køge, Denmark.; Copenhagen, Denmark.
Fiehn AK; Roskilde, Denmark.; Køge, Denmark.; Copenhagen, Denmark.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 194-195.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: a long way to go before precision medicine.
Autorzy :
Amiot A; Department of Gastroenterology, Henri Mondor Hospital, APHP, EA7375, Paris Est-Créteil Univeristy (UPEC), Creteil, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 187.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib.
Autorzy :
Tassone D; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.
Singh S; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Sheng Ding N; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 206-207.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: recognising the efficacy of licensed drug therapies for IBS on bloating-a step in the right direction for targeted treatment?
Autorzy :
Vasant DH; Neurogastroenterology Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 196-197.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: finding the ideal prokinetic for gastroparesis-we are not there yet.
Autorzy :
Mahadeva S; Division of Gastroenterology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 210-211.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply.
Autorzy :
Park JG; Division of Gastroenterology and Hepatology, Department of Medicine, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.; Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, South Korea.
Jung J; Division of Gastroenterology and Hepatology, Department of Medicine, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.
Loomba R; Division of Gastroenterology and Hepatology, Department of Medicine, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.; Department of Family Medicine and Public Health, University of California at San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 216.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply.
Autorzy :
Nelson AD; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Black CJ; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Houghton LA; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Lugo-Fagundo NS; Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Lacy BE; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Ford AC; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 198-199.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: post-reflux swallow-induced peristaltic wave in eosinophilic oesophagitis-more questions than answers? Authors' reply.
Autorzy :
Frazzoni M; Digestive Pathophysiology Unit and Digestive Endoscopy Unit, Baggiovara Hospital, Modena, Italy.
Frazzoni L; Gastroenterology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
de Bortoli N; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 190-191.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: tissue findings fail to predict disease activity or prognosis in microscopic colitis: an opportunity to look at the molecular level.
Autorzy :
Lucendo AJ; Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain.; Instituto de Investigación Sanitaria Princesa, Madrid, Spain.; Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 192-193.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: testing novel interventions for coeliac disease-which outcomes matter?
Autorzy :
Wolf RL; Program in Nutrition, Department of Health and Behavioral Studies, Teachers College, Columbia University, New York City, NY, USA.
Lebwohl B; Department of Medicine, Celiac Disease Center, Columbia University, New York City, NY, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, NY, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 200-201.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing.
Autorzy :
Emrich T; Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.; Department of Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine Main, Mainz, Germany.
Schattenberg JM; Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.; Metabolic Liver Research Program, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 214-215.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Editorial: finding the ideal prokinetic for gastroparesis-we are not there yet. Authors' reply.
Autorzy :
Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Kuo B; Harvard School of Medicine, Boston, MA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 212-213.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: is there a 'precursor' HCC lesion and can it be detected by hepatobiliary contrast-enhanced magnetic resonance imaging?
Autorzy :
Vutien P; Division of Gastroenterology and Hepatology, University of Washington, Seattle, WA, USA.; Department of Medicine Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle, WA, USA.
Ioannou GN; Division of Gastroenterology and Hepatology, University of Washington, Seattle, WA, USA.; Department of Medicine Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 202-203.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Letter: safety of immune checkpoint inhibitors in patients with pre-established microscopic colitis-a single-centre experience.
Autorzy :
Fredrick TW; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Braga Neto MB; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Ramos GP; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Kane S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Raffals LE; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 217-218.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Editorial: post-reflux swallow-induced peristaltic wave in eosinophilic oesophagitis-more questions than answers?
Autorzy :
Rogers BD; Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.; Division of Gastroenterology, Hepatology, and Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.
Gyawali CP; Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 188-189.
Typ publikacji :
Editorial
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies